Cytovance and Precision Biologics Announce Extension of Manufacturing Agreement
News Mar 29, 2014
Cytovance Biologics, Inc. is extending its manufacturing agreement with Precision Biologics, Inc., a Texas-based clinical stage biopharmaceutical company.
Precision Biologics is advancing its clinical trials with its leading monoclonal antibody candidate - referred to as Ensituximab or NEO-102 - which is being developed as a therapeutic drug candidate for pancreatic and colorectal cancers.
Precision has contracted Cytovance Biologics as its CMO to provide technology transfer and additional cGMP manufacturing services of NEO-102 in support of its ongoing Phase 2 clinical trials.
“With this agreement, Precision Biologics is strengthening its longstanding and growing relationship with the scientific professionals of Cytovance,” said Dr. Albine Martin, COO of Precision Biologics, Inc. “Cytovance has been a valuable partner in helping us reach another milestone in our program directed towards the treatment of pancreatic and colorectal cancers.”
“Our state-of-the-art facilities and experienced staff are prepared to continue the delivery of clinical materials for Precision Biologics,” said Darren Head, President and Chief Executive Officer of Cytovance Biologics, Inc.
Head continued, “We are proud to be an established partner with Precision Biologics and support them in their expanded clinical trial program.”
Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to ChemotherapyNews
A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.READ MORE
Induced Pluripotent Stem Cells Could Serve as Cancer VaccineNews
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice suggests another use for iPS cells: training the immune system to attack or even prevent tumors.READ MORE